| 000 | 01863nam a2200337Ia 4500 | ||
|---|---|---|---|
| 001 | 296956 | ||
| 005 | 20160527203326.0 | ||
| 008 | 070427s2007 enka b 001 0 eng | ||
| 010 | _a 2007017884 | ||
| 020 | _a9780470012451 (pbk.) | ||
| 020 | _a0470012455 (pbk.) | ||
| 035 | _a(OCoLC)ocn123962937 | ||
| 035 | _a(OCoLC)123962937 | ||
| 040 |
_aDNLM/DLC _cDLC _dNLM _dBAKER _dBTCTA _dBWKUK _dYDXCP _dDLC |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRS380 _b.W35 2007 |
| 082 | 0 | 0 |
_a615.19 _bW223p _222 |
| 100 | 1 |
_aWalsh, Gary _cDr. _9289245 _2Local |
|
| 245 | 1 | 0 |
_aPharmaceutical biotechnology _bconcepts and applications _cGary Walsh. |
| 260 |
_aChichester, England _aHoboken, NJ _bJohn Wiley & Sons _cc2007. |
||
| 300 |
_axviii, 480 p. _bill. _c26 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aPharmaceuticals, biologics and biopharmaceuticals -- Protein structure -- Gene manipulation and recombinant DNA technology -- The drug development process -- Sources and upstream processing -- Downstream processing -- Product analysis -- The cytokines : the interferon family -- Cytokines : interleukins and tumour necrosis factor -- Growth factors -- Therapeutic hormones -- Recombinant blood products and therapeutic enzymes -- Antibodies, vaccines and adjuvants -- Nucleic-acid- and cell-based therapeutics. | |
| 650 | 0 |
_aPharmaceutical biotechnology. _9263778 _2Local |
|
| 650 | 2 | 2 |
_aPharmaceutical Preparations _9150478 _2Local |
| 650 | 2 | 2 |
_aBiotechnology _962503 _2Local |
| 650 | 1 | 2 |
_aTechnology, Pharmaceutical _9177449 _2Local |
| 856 | 4 | 1 |
_3Table of contents only _uhttp://www.loc.gov/catdir/toc/ecip0717/2007017884.html |
| 856 | 4 | 2 |
_3Contributor biographical information _uhttp://www.loc.gov/catdir/enhancements/fy0739/2007017884-b.html |
| 856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0739/2007017884-d.html |
| 999 |
_c216135 _d216135 |
||